Algernon to Provide Update on its Ifenprodil IPF and Chronic Cough Phase 2 Human Study Featured on BioPub Webcast Hosted by Dr. KSS MD PhD

NEXT STORY
Cytovia Therapeutics and NYSCF Announce Filing of Provisional Patent for iPSC-Derived NK Cells to Produce Unlimited On-Demand NK and CAR-NK Cells for the Treatment of Cancer
PREV STORY
ContraFect Announces Funding Agreement with the Cystic Fibrosis Foundation
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Akari Therapeutics Announces Positive Topline Results from Fully Recruited Phase II Study of Nomacopan in Bullous Pemphigoid Patients

author_avatar
NASDAQ Market News

Global Clinical Trials Market Analysis Report 2021: Phase III Clinical Trials Dominated the Market with a Share of 53.2% in 2020 – Forecast to 2028

author_avatar
NASDAQ Market News

Ascendis Pharma Expands TransCon™ PTH Phase 2 PaTH Forward Clinical Trial to Expedite Enrollment of Subjects Previously Treated with NATPARA® in the United States

author_avatar
NASDAQ Market News